A/s Novo is 10% Owner at Tobira Therapeutics, Inc. (TBRA). They have made 21 open-market trades across 9 companies since 2016, most recently 2017-06-14.
CIK 0001311596
7 open-market purchases totalling $26.6M since 2016, against 14 sales. Across 7 scored buys the stock is up 27.9% at ninety days, and 23.1 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 86% | 86% |
| Avg Move | +18.8% | +15.0% | +27.9% |
| Alpha | +18.0% | +13.2% | +23.1% |
| Scored | 7 | 7 | 7 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 57% | 57% | 21% |
| Avg Move | -1.6% | -21.1% | +93.3% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RETA | SELL | 2017-06-13 | 2017-06-14 | $25.11 | $1.5M | +21.5% | +31.3% | +17.2% |
| RETA | SELL | 2017-06-08 | 2017-06-12 | $25.71 | $5.7M | +14.7% | +33.6% | +15.2% |
| RETA | SELL | 2017-06-05 | 2017-06-07 | $28.24 | $2.5M | +2.7% | +16.7% | +3.7% |
| APEN | SELL | 2017-05-11 | 2017-05-11 | $5.62 | $582K | -7.1% | -2.1% | -19.1% |
| ANAB | BUY | 2017-01-31 | 2017-02-01 | $15.00 | $750K | +37.8% | +34.7% | +56.0% |
| OPHT | SELL | 2016-12-14 | 2016-12-16 | $4.87 | $17.6M | -4.6% | -8.7% | -29.2% |
| RARX | BUY | 2016-10-31 | 2016-11-02 | $13.00 | $3.2M | +8.4% | +0.4% | +23.5% |
| IRTC | BUY | 2016-10-25 | 2016-10-26 | $17.00 | $1.7M | -9.8% | +12.5% | +16.9% |
| CLCD | BUY | 2016-09-09 | 2016-09-13 | $20.00 | $2.0M | +39.8% | +63.3% | +66.2% |
| TBRA | SELL | 2016-07-11 | 2016-07-13 | $12.02 | $710K | -62.3% | -61.4% | +240.7% |
| TBRA | SELL | 2016-07-05 | 2016-07-07 | $12.20 | $1.1M | -8.1% | -67.5% | +235.6% |
| TBRA | SELL | 2016-06-30 | 2016-06-30 | $12.58 | $341K | -6.3% | -67.8% | +211.6% |
| TBRA | SELL | 2016-06-29 | 2016-06-30 | $12.63 | $203K | -6.3% | -67.8% | +211.6% |
| TBRA | SELL | 2016-06-28 | 2016-06-30 | $13.77 | $288K | -6.3% | -67.8% | +211.6% |
| TBRA | SELL | 2016-06-28 | 2016-06-30 | $13.04 | $871K | -6.3% | -67.8% | +211.6% |
| TBRA | SELL | 2016-06-06 | 2016-06-07 | $10.37 | $1.9M | +15.0% | +14.4% | -53.0% |
| RETA | BUY | 2016-06-01 | 2016-06-02 | $11.00 | $8.3M | +37.2% | +12.0% | +20.0% |
| OPHT | SELL | 2016-05-24 | 2016-05-25 | $49.00 | $63.7M | +12.2% | +2.1% | +7.9% |
| CRVS | BUY | 2016-05-12 | 2016-05-16 | $10.00 | $700K | +21.3% | +0.4% | +19.5% |
| CRVS | BUY | 2016-03-29 | 2016-03-30 | $15.00 | $10.0M | -3.0% | -18.2% | -6.7% |
| TBRA | SELL | 2016-03-02 | 2016-03-04 | $6.80 | $1.3M | +18.3% | +17.7% | +41.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| OPHT | 1,405,487 | $2.0M |
| Total | $712.3M |
Shares reported on the most recent Form 4, priced at the 2017-06-14 close.
| Scored | 14 | 14 | 14 |